Spermiogenic germ cell phase-specific DNA damage following cyclophosphamide exposure

Area of Science:

• Reproductive toxicology
• Spermatogenesis research
• Genotoxicology

Background:

• Spermatozoa quality is crucial for successful embryo development.
• Chemotherapeutic agents like cyclophosphamide can induce DNA damage in germ cells.
• Understanding the timing of germ cell susceptibility to DNA damage is vital.

Purpose of the Study:

• To determine the phase specificity of spermiogenic germ cell susceptibility to cyclophosphamide-induced DNA damage.
• To investigate the effects of different cyclophosphamide dosing schedules on DNA damage in spermatozoa.
• To correlate DNA damage timing with critical sperm chromatin remodeling events.

Main Methods:

• Adult male rats were administered cyclophosphamide via acute, subchronic, or chronic dosing schedules.
• Spermatozoa were collected at 14, 21, and 28 days post-treatment to assess exposure during different spermiogenesis phases.
• DNA strand breaks in spermatozoa were quantified using the comet assay.

Main Results:

• Acute high-dose cyclophosphamide showed minimal DNA damage.
• Subchronic exposure resulted in a dose-related increase in DNA damage, with peak damage observed at 21 days, indicating sensitivity in step 9-14 spermatids.
• Low-dose chronic exposure led to significant DNA damage accumulation, surpassing acute or short-term subchronic exposure levels.

Conclusions:

• Cyclophosphamide-induced DNA damage in rat spermatozoa is germ cell phase-specific.
• Maximal damage occurs during critical sperm chromatin remodeling phases (histone hyperacetylation, transition protein deposition).
• Disruption of chromatin remodeling by DNA strand breaks may negatively impact sperm chromatin structure and subsequent embryo development.